Pharmacokinetic Modeling of Systemic Uptake Following Pulmonary Delivery of a Macromolecular Drug in a Sustained Release Formulation

Journal of Aerosol Medicine ◽

10.1089/jam.1995.8.317 ◽

1995 ◽

Vol 8 (4) ◽

pp. 317-329 ◽

Author(s):

ZVI TEITELBAUM ◽

DAVID B. BENNETT

Keyword(s):

Sustained Release ◽

Pulmonary Delivery ◽

Pharmacokinetic Modeling ◽

Release Formulation ◽

Sustained Release Formulation ◽

Macromolecular Drug

Download Full-text

Population Pharmacokinetic Modeling After Repeated Administrations of RBP-6000, a New, Subcutaneously Injectable, Long-Acting, Sustained-Release Formulation of Buprenorphine, for the Treatment of Opioid Use Disorder

The Journal of Clinical Pharmacology ◽

10.1002/jcph.665 ◽

2016 ◽

Vol 56 (7) ◽

pp. 806-815 ◽

Author(s):

Celine M. Laffont ◽

Roberto Gomeni ◽

Christian Heidbreder ◽

J. P. Jones ◽

Azmi F. Nasser

Keyword(s):

Sustained Release ◽

Opioid Use Disorder ◽

Pharmacokinetic Modeling ◽

Population Pharmacokinetic ◽

Release Formulation ◽

Sustained Release Formulation ◽

Population Pharmacokinetic Modeling ◽

Repeated Administrations ◽

Download Full-text

Population pharmacokinetic modeling and simulation to guide dose selection for RBP-7000, a new sustained-release formulation of risperidone

The Journal of Clinical Pharmacology ◽

10.1002/jcph.366 ◽

2014 ◽

Vol 55 (1) ◽

pp. 93-103 ◽

Author(s):

Celine M. Laffont ◽

Roberto Gomeni ◽

Bo Zheng ◽

Christian Heidbreder ◽

Paul J. Fudala ◽

...

Keyword(s):

Sustained Release ◽

Modeling And Simulation ◽

Pharmacokinetic Modeling ◽

Population Pharmacokinetic ◽

Dose Selection ◽

Release Formulation ◽

Sustained Release Formulation ◽

Population Pharmacokinetic Modeling ◽

Selection For ◽

Pharmacokinetic Modeling And Simulation

Download Full-text

Development of Denticap, a Matrix Based Sustained Release Formulation for Treatment of Toothache, Dental Infection and Other Gum Problem

Current Drug Delivery ◽

10.2174/156720109787846270 ◽

2009 ◽

Vol 6 (2) ◽

pp. 199-207 ◽

Author(s):

Biswajit Mukherjee ◽

Gopa Roy ◽

Soma Ghosh

Keyword(s):

Sustained Release ◽

Dental Infection ◽

Release Formulation ◽

Sustained Release Formulation

Download Full-text

Plasma Levels and Negative Chronotropic Effect of Metoprolol following Single Doses of a Conventional and Sustained Release Formulation C. P. Quarterman, M. J. Kendall, R. G. Welling vol. 15, 97?103 (1979)

European Journal of Clinical Pharmacology ◽

10.1007/bf00562065 ◽

1979 ◽

Vol 16 (3) ◽

pp. 219-219

Author(s):

D. A. Piercy ◽

C. P. Quarterman ◽

M. J. Kendall ◽

P. G. Welling

Keyword(s):

Sustained Release ◽

Plasma Levels ◽

Chronotropic Effect ◽

Release Formulation ◽

Sustained Release Formulation ◽

Negative Chronotropic Effect

Download Full-text

Sustained release formulation of an anti-tuberculosis drug based on para-amino salicylic acid-zinc layered hydroxide nanocomposite

Chemistry Central Journal ◽

10.1186/1752-153x-7-72 ◽

2013 ◽

Vol 7 (1) ◽

Author(s):

Bullo Saifullah ◽

Mohd Zobir Hussein ◽

Samer Hasan Hussein-Al-Ali ◽

Palanisamy Arulselvan ◽

Sharida Fakurazi

Keyword(s):

Salicylic Acid ◽

Sustained Release ◽

Release Formulation ◽

Sustained Release Formulation ◽

Amino Salicylic Acid ◽

Zinc Layered Hydroxide

Download Full-text

P01-45 Twenty-four months efficacy and safety of LB03002, a new sustained release formulation of rhGH, in children with GHD: Extension of a phase III randomized multicentre study

Growth Hormone & IGF Research ◽

10.1016/s1096-6374(12)60124-5 ◽

2012 ◽

Vol 22 ◽

pp. S48

Author(s):

P. Saenger ◽

V. Khadilkar ◽

K.A. Radjuk ◽

E. Bolshova ◽

R. Khadgawat ◽

...

Keyword(s):

Sustained Release ◽

Multicentre Study ◽

Phase Iii ◽

Efficacy And Safety ◽

Release Formulation ◽

Sustained Release Formulation

Download Full-text

Pharmacokinetics of acipimox and of its N-deoxy metabolite following single and repeated oral administration of a sustained release formulation to healthy volunteers

International Journal of Pharmaceutics ◽

10.1016/0378-5173(93)90399-z ◽

1993 ◽

Vol 95 (1-3) ◽

pp. 127-133

Author(s):

C. Efthymiopoulos ◽

D.M.F. Edwards ◽

M. Strolin-Benedetti ◽

F. Ruff ◽

C. Advenier ◽

...

Keyword(s):

Sustained Release ◽

Oral Administration ◽

Healthy Volunteers ◽

Release Formulation ◽

Sustained Release Formulation

Download Full-text

Controlled, eight-hour haemodynamic study of a sustained-release formulation of isosorbide dinitrate in moderate left ventricular failure

European Journal of Clinical Pharmacology ◽

10.1007/bf00542156 ◽

1984 ◽

Vol 27 (3) ◽

pp. 259-263 ◽

Author(s):

O. Dubourg ◽

P. Gueret ◽

A. Ferrier ◽

J. C. Farcot ◽

M. Terdjman ◽

...

Keyword(s):

Sustained Release ◽

Isosorbide Dinitrate ◽

Left Ventricular ◽

Left Ventricular Failure ◽

Ventricular Failure ◽

Release Formulation ◽

Sustained Release Formulation ◽

Haemodynamic Study

Download Full-text

▾ Piretanide for hypertension

Drug and Therapeutics Bulletin ◽

10.1136/dtb.23.11.43 ◽

1985 ◽

Vol 23 (11) ◽

pp. 43-44

Keyword(s):

Glucose Tolerance ◽

Sustained Release ◽

Loop Diuretic ◽

Plasma Potassium ◽

Release Formulation ◽

Sustained Release Formulation ◽

Treatment Of Hypertension

Piretanide is a loop diuretic recently marketed in a sustained-release formulation (Arelix - Hoechst) solely for the treatment of hypertension (rather than as a general diuretic). The manufacturer claims that piretanide has several advantages over the thiazides, including little or no effect on plasma potassium and magnesium, and no impairment of glucose tolerance.

Download Full-text

Biochronomer™ technology and the development of APF530, a sustained release formulation of granisetron

Journal of Experimental Pharmacology ◽

10.2147/jep.s68880 ◽

2014 ◽

pp. 15 ◽

Author(s):

Thomas Ottoboni ◽

Mark Gelder ◽

Erin O’Boyle

Keyword(s):

Sustained Release ◽

Release Formulation ◽

Sustained Release Formulation

Download Full-text